Bush Administration Considering Physician Ratings

Publication
Article
OncologyONCOLOGY Vol 15 No 7
Volume 15
Issue 7

Thomas Scully, the new administrator of the Health Care Financing Administration, is moving fast to make improvements to Medicare. A proposal to collect and publish quality and outcome information on health-care practitioners who treat

Thomas Scully, the new administrator of the Health CareFinancingAdministration, is moving fast to make improvements to Medicare.A proposal to collect and publish quality and outcome information on health-carepractitioners who treat Medicare patients will apparently be included in apackage of reforms that Mr. Scully plans to unveil.

In a speech at the USChamber of Commerce, Mr. Scully said he had a mandate to "shake up"the agency. He said the Bush administration would give the elderly moreinformation on their health insurance options, and publicize data on the qualityof care provided by hospitals, doctors, nursing homes, and home care agencies.

Sen. Bill Frist (R-Tenn), formerly a practicing physician, welcomed the overhaulbut said the administration must be careful to include hospitals and others inthe deliberations. "We need to make sure that we don’t unduly increasethe burdens on doctors and health-care providers who already face increasingregulatory constraints,’’ he said. Mr. Scully has not disclosed what kind ofratings system he has in mind.

Experiments with physician systems in Portland,Oregon, and Cincinnati, Ohio, have left some physicians exasperated. NationalResearch Corp, headquartered in Lincoln, Nebraska, rated primary care physiciansin those two cities in four areas of "care." Health plans in thosecities provided the names of patients and physicians.

"Our response was, it’sworthless," said Jim Kronenberg, associate executive director of thePortland-based Oregon Medical Association. "It’s got this sort of MickeyMouse seal of approval without any real hard data."

Recent Videos
For example, you have a belt of certain diseases or genetic disorders that you come across, such as sickle cell disease or thalassemia, that are more prevalent in these areas.
Recent findings presented at ASTRO 2025 suggest an “exciting opportunity” to expand the role of radiation oncology in different non-malignant indications.
The 3 most likely directions of radiotherapy advancements come from new technology, combinations with immunotherapy, and the incorporation of particle therapy.
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
4 experts in this video
4 experts in this video
Distance and training represent 2 major obstacles to making radiotherapy available to more patients with cancer across the world.
7 experts are featured in this series.
Related Content